Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-21.19	24.64	31.26
Graham Fair Price	-4.47	1.99	2.08
PEG	64.82	-1.13	0.69
Price/Book	8.02	2.07	1.92
Price/Cash Flow	inf	0.00	59.12
Prices/Earnings	32.02	11.24	8.51
Price/Sales	4.78	5.37	5.12
Price/FCF	inf	0.00	59.12
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	114.54	0.56	0.26
Operating Margin	51.72	0.18	0.12
ROA	-17.04	0.02	0.03
ROE	0.06	0.05	-18.18
ROIC	0.03	0.03	29.31
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	< 0.005	243.69
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.34	0.65	90.43
EPS QOQ	0.12	-0.10	-19.90
FCF QOQ	0.95	-1.00	5.33
Revenue QOQ	0.02	0.09	268.27
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	72.46	103.08	42.26
Days Sales Outstanding (DSO)	76.86	84.13	9.47
Inventory Turnover	1.24	0.87	-29.70
Debt/Capitalization	0.34	0.34	0.11
Quick Ratio	0.94	0.99	6.26
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.85	1.95	5.61
Cash	0.24	0.27	11.39
Capex	-0.06	0.00	inf
Free Cash Flow	0.06	0.00	inf
Revenue	0.69	0.75	8.88
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.42	1.39	-2.53
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.67	3.74	-34.12
Naive Interpretation	Member

06 - Financial Health · Weak

Rating